🔗 Share this article

An underground market for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Experimental Treatment Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are urged to message these accounts privately for source information, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where communities with thousands of members share comparison images, injection guides and claims of rapid British shipping. Vendors promote the substance there before directing customers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and pharmacists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals administering substances of uncertain source.

Several experts said the popularity for retatrutide could be linked to the rising price of licensed slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be marketed or distributed for human use under the British medical regulations.

Some influencers try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still breach medicines, advertising, and consumer regulations, risking fines, prosecution or prison.

Platform Response and Material Elimination

Based on the social media company, the platform has taken down violative material and banned related hashtags and query recommendations. The company said it was committed to maintaining the platform secure and allocating resources in enhancing compliance measures.

Digital Marketplace Activities

Investigations also found groups with up to nine thousand members marketing the experimental drug using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately brings up channels with numerous of users, filled with images of slimming results, positive testimonials and step-by-step instructions for mixing or administering at home.

After moments of entering one group, a seller posted WhatsApp details, where the majority of transactions take place. The seller provided an guidebook and promised shipping within 48 hours. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one inquired about body mass, medical conditions or past usage.

Product Details and Pricing

Within these communities, posts show black plastic parcels with postal service stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When asked how much time a pen should last, vendors give conflicting responses varying between a several days to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service stated it actively moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting substances they can’t verify. Even if the research behind retatrutide is valid, these online versions may not include what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to current price rises for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her staff has previously encountered individuals harmed by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company investigational substance not yet approved … may subject patients to potentially significant health risks”.